Concepedia

W F Owen

WF

Statistics

Publications

20

Citations

3.1K

H-Index

20

Active since

1986

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

University of California, Los Angeles

University of California, San Francisco

GGD Amsterdam

W F Owen is an author at Harvard University specializing in life sciences, immunology, and inflammation.

Publications per year

1986–2001

20

Publications

20

Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.

M.E. Rothenberg, W F Owen, David S. Silberstein et al. · Journal of Clinical Investigation · 1988 · 476 citations · Full text

, , +14

Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.

W F Owen, Marc E. Rothenberg, David S. Silberstein et al. · The Journal of Experimental Medicine · 1987 · 394 citations · Full text

, , +9

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

William Drew, Richard C. Miner, David F. Busch et al. · The Journal of Infectious Diseases · 1991 · 371 citations

, , +17

IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity.

M.E. Rothenberg, J Petersen, R L Stevens et al. · The Journal of Immunology · 1989 · 284 citations · Full text

, , +9

Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor.

David S. Silberstein, W F Owen, Judith C. Gasson et al. · The Journal of Immunology · 1986 · 281 citations · Full text

, , +13

1–5 of 20